$VERA

$31.13▲ +0.3% YTD

6 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

CP $31.13▲ +0.3%Oct 2, 2026 · ThinkSabio Blog

$VERA - Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking…

News

VERA ▲ +2.7% - Vera Therapeutics, Inc.

CP $34.95▲ +2.7%Sep 15, 2026 · ThinkSabio Blog

$VERA - Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3…

News

VERA ▲ +2.9% - Vera Therapeutics, Inc.

CP $35.89▲ +2.9%Sep 4, 2026 · ThinkSabio Blog

$VERA - Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News

VERA ▼ -1.1% - Vera Therapeutics, Inc.

CP $33.70▲ -1.1%Sep 1, 2026 · ThinkSabio Blog

$VERA - Vera Therapeutics to Participate at Upcoming Investor Conferences…

SEC 13D/G

VERA - Vera Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$31.70▼ -34.80%Aug 14, 2026 · ThinkSabio Blog

$VERA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VERA Vera Therapeutics, Inc. : $31.70 Sector: Healthcare | YTD:…

SEC 13D/G

$VERA SEC Filing Update (30-JUL-2026) | ThinkSabio - Stocks Simplified

$32.56▼ -33.03%Jul 30, 2026 · ThinkSabio Blog

$VERA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #VERA : $32.56 Sector: Healthcare | YTD: 🔽 -33.03% The SEC discl…